Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis.
Journal: Neurology
Published: April 09, 2026
De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 19, 2026
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis.
Journal: Neurology
Published: December 22, 2025
Improving quality, affordability, and equity of multiple sclerosis care.
Journal: Annals of clinical and translational neurology
Published: October 09, 2020
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases.
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases.
Journal: JAMA neurology
Published: October 21, 2014
Immunomodulatory agents and risk of postpartum multiple sclerosis relapses.
Journal: The Permanente journal
Published: March 15, 2014
The incidence of clinically isolated syndrome in a multi-ethnic cohort.
Journal: Journal of neurology
Published: January 08, 2014
Incidence of multiple sclerosis in multiple racial and ethnic groups.
Journal: Neurology
Published: May 08, 2013
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
Journal: Neurology
Published: February 01, 2013
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Journal: Clinical immunology (Orlando, Fla.)
Published: December 08, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026